Dexcom Inc (DXCM)
Sector: Healthcare
Industry: Surgical & Medical Instruments & Apparatus
Country: United States
Exchange: NASDAQ
Market cap: $33.18B
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
Latest financial period: June 30, 2026
Filed with the SEC: July 30, 2026
Estimated earnings date: October 29, 2026
Profit #229 of 1484 companies
| | Jun 26 | Mar 26 | Dec 25 | Sep 25 |
|---|
| ROE/ROA | 84.3% | 83.6% | 84.1% | 82.4% |
Growth #243 of 1484 companies
Payout #1117 of 1484 companies
Safety #762 of 1484 companies
Price #862 of 1484 companies
